Introduction {#sec1-1}
============

Early miscarriage and pregnancy-associated problems are of major concern. The reason behind this is not only genetical or physiological but also environmental and modern lifestyle. Moderate levels of inflammatory reactions are also pre-requisite during the first trimester of pregnancy for implantation and embryo development. These early stages of pregnancy resemble 'an open wound'[@ref1]. For invasion and proper blood supply of embryo neovascularization and tissue remodelling occur during early gestational weeks of pregnancy[@ref1][@ref2]. An appropriate tuning of anti-inflammatory and inflammatory mediators is required for adequate repair of the uterine epithelium and the removal of cellular debris. Thus, this critical period of pregnancy is marked by expression of specific cytokines and adhesion molecules by both foetal and maternal side ensuring successful pregnancy. Any alteration and dysfunction of this balanced inflammatory milieu and any perturbation or disturbance in this during the critical period result in miscarriage or pregnancy-associated complications[@ref3].

Earlier studies in mice and human revealed the role of important calcium (Ca^2+^)-binding S100 proteins in pregnancy-related complications[@ref4][@ref5]. This group of proteins helps in the recruitment of leucocytes at inflammatory site and functions like cytokines[@ref4]. These proteins regulate a variety of cellular functions such as cellular differentiation, cell cycle progression and energy intracellular signal transduction by interacting with several other mediatory proteins[@ref6]. S100 proteins were found to be tumorigenic in function and get elevated in several cancer and melanoma cases[@ref6]. An earlier study in human also showed elevated level of S100 group proteins in high-risk pregnancy cases, in amniotic fluid and cord blood of foetus with brain damage[@ref7]. The role of S100 protein in immunomodulation of high-risk pregnancy cases is an active area of research and clinical investigation. This review focuses on new advances regarding the role of S100 protein in diagnosis and treatment of high-risk pregnancies.

S100 protein structure and function {#sec1-2}
===================================

Ca^2+^ regulates several cellular processes and acts as a messenger[@ref8]. Many Ca^2+^-binding proteins, having the EF-hand structural motif, make Ca^2+^ signalling network in combination with many molecular components[@ref9]. S100 proteins are the largest subgroup within this family of Ca^2+^-binding proteins and found to be involved in several diseases such as rheumatoid arthritis, acute inflammatory lesions, cardiomyopathy, Alzheimer\'s disease and cancer[@ref10][@ref11].

S100 proteins are acidic, Ca^2+^-binding proteins initially identified in the brain of several mammalian species and called S100 because of their solubility in 100 per cent ammonium sulphate[@ref12][@ref13]. Genes responsible for the synthesis of most S100 proteins are located on human chromosomes 1q21[@ref14]. Initially, S100 proteins were found to be located in glial cells and used as a marker of glial cell differentiation and mammalian brain development[@ref15][@ref16][@ref17]. S100 protein family has 21 members having the same basic structural moiety but entirely different function, and are found in cerebrospinal fluid, urine, serum, seminal plasma and saliva mainly in active disease states. These proteins are found to be present in Ca^2+^ free (apo); Ca^2+^-bound and target bound states as a symmetric dimer, with each monomer containing two EF-hand motifs[@ref18]. The EF-hand motif on N-terminal site contains helix I with pseudo Ca^2+^-binding site, and the EF-hand of C-terminal is associated with helix III, helix IV and second Ca^2+^-binding site ([Fig. 1](#F1){ref-type="fig"}).

![Schematic diagram represents the chromosomal location, structure and various functions of S100 proteins. *Source*: Refs [@ref14][@ref18].](IJMR-148-100-g001){#F1}

S100 proteins undergo structural and conformational changes on binding with Ca^2+^, and this conformational change allows interaction of these proteins with target molecules. Activated S100 proteins perform all cellular functions by both extracellular and intracellular methods ([Table I](#T1){ref-type="table"}). All S100 proteins function in the form of dimmers, and only S100G protein acts as monomer[@ref39]. A few hetero-dimmers are also reported: S100A1/B, S100A8/A9, S100A1/A4 and S100A1/P[@ref40][@ref41]. S100 proteins can also form active tetramers, hexamers or larger oligomers (S100B[@ref42], S100A4[@ref43], S100A8/A9[@ref44] and S100 A12[@ref45]).

###### 

Functions of S100 proteins

  S100 protein   Localization                                                                                                         Functions                                                                            References
  -------------- -------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------ ------------------
  S100A1         Skeletal system, neurons and cardiomyocytes                                                                          Functioning of cardiomyocytes and skeletal muscle, regulation of energy metabolism   [@ref19]
  S100A2         Cancerous cells                                                                                                      Down regulated in many cancers                                                       [@ref20]
  S100A3         Localized in root of hair and some cancerous astrocytes                                                              Differentiation of epithelial cell and hair cuticular barrier formation              [@ref21]
  S100A4         Tumorous tissue                                                                                                      Stimulating cell proliferation, mobility and migration                               [@ref22]
  S100A5         Tumorous tissue                                                                                                      Elevated in bladder cancer cases                                                     [@ref23]
  S100A6         Tumorous tissue                                                                                                      Cell cycle progression, cytoskeletal movement and tumour formation                   [@ref24]
  S100A7         Tumorous tissue                                                                                                      Cytoskeletal functions, adhesion and migration, upregulated in breast cancer         [@ref25]
  S100A8         Macrophages, dendritic cells, microvascular endothelial cells                                                        Necessary for embryo implantation, promotes myeloid cells differentiation            [@ref5]
  S100A9         Neutrophils, dendritic cells                                                                                         Inhibits myeloid cells differentiation, induces inflammation                         [@ref26]
  S100A10        Neutrophils, dendritic cells                                                                                         Interacts with serotonin receptors and control depression like status                [@ref27]
  S100A11        Neutrophils, dendritic cells                                                                                         Controls cell proliferation and survival                                             [@ref28]
  S100A12        In neutrophils and inducible in macrophages                                                                          Regulates VSCM functions                                                             [@ref29]
  S100A13        Fibroblasts, osteoblasts and melanoma cells                                                                          Regulates secretion factor (FGF)- 1 and IL-1α from various cell types                [@ref30]
  S100A14        Tumorous tissue                                                                                                      Inhibits cancer progression *via* suppression of p53 mediated pathway                [@ref31]
  S100A15        ‑                                                                                                                    Acts as an extracellular factor                                                      [@ref32]
  S100A16        Tumorous tissue                                                                                                      Disrupts insulin sensitivity and promotes obesity                                    [@ref33]
  S100B          Astrocytes, certain neuronal populations, Schwann cells, melanocytes, chondrocytes, adipocytes, skeletal myofibers   Stimulator of cell cycle and migration and an inhibits apoptosis                     [@ref34]
  S100G          Neutrophils, dendritic cells                                                                                         Maintains cytosolic Ca^2+^ concentration                                             [@ref35]
  S100P          Tumorous tissue                                                                                                      Cell migration and potentially metastasis                                            [@ref36]
  S100Z          Tumorous tissue                                                                                                      Down regulated in several tumours                                                    [@ref37][@ref38]

VSCM, vascular smooth muscle cell; FGF, fibroblast growth factor; IL, interleukin

S100 receptors {#sec1-3}
==============

Function of S100 proteins is determined by their oligomeric forms and their respective binding partners[@ref46]. Extracellular S100 proteins act via activation of surface receptors such as G protein-coupled receptors, receptor for advanced glycation end products (RAGEs) and toll-like receptors and aid in regulatory processes such as cell proliferation, differentiation and migration in normal as well as different pathological conditions. Intracellular S100 proteins also act via interaction with different target enzymes, cytoskeleton subunits, receptors and transcription factors or nucleic acids regulate Ca^2+^ homeostasis, energy metabolism and cellular differentiation.

Role of S100 proteins in high-risk pregnancy cases {#sec1-4}
==================================================

In maternal endometrium, S100 proteins are expressed by both immune cells and non-immune cells. A few groups of S100 proteins such as S100A8, S100A9 and S100A12 are mainly secreted from myeloid origin of immune cells such as granulocytes, monocytes and early stages of macrophages[@ref4]. As myeloid origin cells are well known as crucial regulators for other immune cells (T, Treg, uNK and non-inflammatory macrophages and neutrophils cells) in successful pregnancy, any alteration in inflammatory or immunomodulatory stage may change S100 protein levels[@ref4] ([Fig. 2](#F2){ref-type="fig"}). Some non-immune cells such as mice placenta and ovaries of cow and pig have been reported to secrete some S100 group proteins such as S100A1, S100A6, S100A9 and S100A8[@ref5][@ref48].

![Schematic diagram represents interaction of S100 proteins with immune cells for the regulation of various hallmark processes of pregnancy. IFN-γ, interferon gamma; IL, interleukin; TH, T helper; TNF-α, tumor necrosis factor alpha; uNK, uterine natural killer. *Source*: Refs [@ref4][@ref47].](IJMR-148-100-g002){#F2}

S100 proteins regulate embryo implantation, intrauterine growth and normal foetal brain development during pregnancy. S100 family proteins have been found to be dysregulated in various endometrial diseases ([Table II](#T2){ref-type="table"}). S100A8 proteins are found to be down regulated in receptive phase of endometrium[@ref57]. S100A8 protein recruits mouse and human neutrophils and macrophages at the site of inflammation[@ref58]. Endometrial epithelium and stromal cells also showed expression of S100A10 protein during the implantation window and found to play an important role in endometrial receptivity[@ref54]. The expression of these proteins have been found to be down regulated in the endometrium of infertile patients[@ref54][@ref55]. This is the reason behind the failure of 30 per cent of embryo implantation in assisted reproduction.

###### 

Altered expression profile of S100 proteins in various human pregnancy-related diseases

  Pregnancy-related diseases                  S100 family                       References
  ------------------------------------------- --------------------------------- -----------------
  Pregnancy-associated with Down syndrome     Upregulated S100ß                 [@ref49]
  IUGR                                        Upregulated S100ß                 [@ref50]
  SGA babies SGA foetus                       No change in S100ß                [@ref51]
  Pre eclampsia+IUGR                          Upregulated S100ß                 [@ref52]
  Miscarriage                                 Down regulated S100A11            [@ref53]
                                              Up regulated S100A8, S100A9       [@ref4][@ref47]
  Pre eclampsia                               Up regulated S100ß                [@ref52]
  Pre-term labour                             Up regulated S100ß                [@ref51]
  IVF failure                                 Down regulated S100A11, S100A10   [@ref54]
  PCOS                                        Up regulated S100A12              [@ref55]
  Endometriosis                               Up regulated S100A4               [@ref56]
  Endometriosis associated with infertility   Up regulated S100P                [@ref56]
  Gestational diabetes                        Up regulated S100A9               [@ref57]

IUGR, intrauterine growth restriction; SGA, small for gestational age; IVF, *in vitro* fertilization; PCOS, polycystic ovary syndrome

A study conducted by Passey *et al*[@ref5] showed that S100A8 knockout gene in mice caused a late embryonic lethality and suggested its role in fetomaternal tolerance. A study on transcriptome-based analysis in equine pregnancy revealed that S100A6 protein was expressed in conceptus side, and S100A2, S100A4, S100A6 and S100A8 were present in maternal endometrium on day 16 in mare[@ref59]. A key role of these proteins has been suggested in epidermal growth factor-stimulated embryo adhesion, acquisition of endometrial receptivity, immunotolerance, apoptosis of dead endometrial epithelial cells and prolactin secretion, a marker for onset of decidualization[@ref60][@ref61]. S100 β protein is also found to be up regulated in trisomy cases, and their upregulation is an indicator of a brain lesion in developing foetus[@ref58]. Thus, monitoring of S100 protein could be helpful in the detection of brain distress in intrauterine growth-retarded (IUGR) foetuses[@ref50]. In preeclampsia and IUGR cases, amniotic fluid S100B protein concentration was found to be elevated[@ref23].

Conclusion {#sec1-5}
==========

The present review summarizes the role of S100 proteins in high-risk pregnancy cases along with its structure and mechanism of action. This also covers the importance of S100 proteins as a main player of successful implantation, embryonic growth and birth of physically and mentally healthy child. The optimal expression and signalling of S100 proteins, at particular stages of pregnancy is a pre-requisite for avoiding high-risk pregnancy cases and can serve as therapeutic target and prognostic biomarker in pregnancy-related complications.
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